PROM1 and cancer: The results also confirmed highly specific binding to both cancer cell types that were substantially inhibited to 2.8 ± 0.7% and 13.9 ± 3.1% of unblocked levels by 500 nM of cold anti-CD133 IgG, respectively (both P < 0.001; Figure 2(b)).